Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country

Clinical Infectious Diseases

Volumn 59, Issue 9, 2014, Pages 1332-1345

  Taron Brocard, Clement ^a   Chenadec, Jerome Le ^a   Faye, Albert ^b,c   Dollfus, Catherine ^d   Goetghebuer, Tessa ^e   Gajdos, Vincent ^a,f,g   MarcLabaune, Jean ^h   Perilhou, Anais ^a   Mandelbrot, Laurent ^a,b,i   Blanche, Stephane ^b,j   Warszawski, Josiane ^a,g  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c AP HP Hôpital Robert Debré   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^f HÔPITAL ANTOINE BÉCLÈRE   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

^h CROIX ROUSSE HOSPITAL   (France)

ⁱ HÔPITAL LOUIS MOURIER   (France)

^j HÔPITAL NECKER ENFANTS MALADES   (France)

more..

Author keywords

CD4; HIV; infants; mother to child transmission; pregnancy

Indexed keywords

RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BACTERIAL INFECTION; CD4 LYMPHOCYTE COUNT; EXPOSURE VARIABLE; FEMALE; HAZARD RATIO; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MOTHER CHILD RELATION; NEWBORN; BACTERIAL INFECTIONS; CHEMICALLY INDUCED; FRANCE; HIV INFECTIONS; IMMUNOLOGY; INFANT, NEWBORN, DISEASES; KAPLAN MEIER METHOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; RETROSPECTIVE STUDY; VERTICAL TRANSMISSION;

BACTERIAL INFECTIONS; CD4 LYMPHOCYTE COUNT; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KAPLAN-MEIER ESTIMATE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES;

EID: 84913593607     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu586     Document Type: Article

References (40)

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173-80.
2. Marinda E, Humphrey JH, Iliff PJ, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007; 26:519-26.
3. Koyanagi A, Humphrey JH, Ntozini R, et al. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011; 30:45-51.
4. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, et al. Mortality in HIVinfected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr 2006; 41:504-8.
5. Landes M, van Lettow M, Chan AK, Mayuni I, Schouten EJ, Bedell RA. Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi. PloS One 2012; 7:e47337.
6. Slogrove A, Reikie B, Naidoo S, et al. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr 2012; 58:505-8.
7. Singh HK, Gupte N, Kinikar A, et al. High rates of all-cause and gastroenteritis-related hospitalization morbidity and mortality among HIVexposed Indian infants. BMC Infect Dis 2011; 11:193.
8. Kuhn L, Kasonde P, Sinkala M, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis 2005; 41:1654-61.
9. Mussi-Pinhata MM, Freimanis L, Yamamoto AY, et al. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study. Pediatrics 2007; 119:e694-704.
10. Epalza C, Goetghebuer T, Hainaut M, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010; 126:e631-8.
11. Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol 2014; 176:11-22.
12. Chougnet C, Kovacs A, Baker R, et al. Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis 2000; 181:1590-7.
13. Velilla PA, Montoya CJ, Hoyos A, Moreno ME, Chougnet C, Rugeles MT. Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells. Clin Immunol Orlando Fla 2008; 126:243-50.
14. Clerici M, Saresella M, Colombo F, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96:3866-71.
15. Miles DJC, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants. Immunology 2010; 129:446-54.
16. Slogrove AL, Cotton MF, Esser MM. Severe infections in HIV-exposed uninfected infants: clinical evidence of immunodeficiency. J Trop Pediatr 2010; 56:75-81.
17. Borges-Almeida E, Milanez HMBPM, Vilela MMS, et al. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns. BMC Infect Dis 2011; 11:38.
18. Romano MF, Buffolano W, Bisogni R, et al. Increased CD154 expression in uninfected infants born to HIV-positive mothers exposed to antiretroviral prophylaxis. Viral Immunol 2006; 19:363-72.
19. Vigano A, Saresella M, Schenal M, et al. Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers. AIDS Lond Engl 2007; 21:245-8.
20. Kolte L, Rosenfeldt V, Vang L, et al. Reduced thymic size but no evidence of impaired thymic function in uninfected children born to human immunodeficiency virus-infected mothers. Pediatr Infect Dis J 2011; 30:325-30.
21. Reikie BA, Adams RCM, Leligdowicz A, et al. Altered innate immune development in HIV-exposed uninfected infants. J Acquir Immune Defic Syndr 2014; 66:245-55.
22. Economides A, Schmid I, Anisman-Posner DJ, Plaeger S, Bryson YJ, Uittenbogaart CH. Apoptosis in cord blood T lymphocytes from infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol 1998; 5:230-4.
23. Mazzola TN, da Silva MTN, Abramczuk BM, et al. Impaired bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants. AIDS Lond Engl 2011; 25:2079-87.
24. Abramczuk BM, Mazzola TN, Moreno YMF, et al. Impaired humoral response to vaccines among HIV-exposed uninfected infants. Clin Vaccine Immunol 2011; 18:1406-9.
25. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. J Am Med Assoc 2011; 305:576-84.
26. De Moraes-Pinto MI, Verhoeff F, Chimsuku L, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998; 79:F202-205.
27. Farquhar C, Nduati R, Haigwood N, et al. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody. J Acquir Immune Defic Syndr 1999 2005; 40:494-7.
28. Cumberland P, Shulman CE, Maple PAC, et al. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis 2007; 196:550-7.
29. Scott S, Moss WJ, Cousens S, et al. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis 2007; 45:1417-24.
30. Bunders M, Pembrey L, Kuijpers T, Newell M-L. Evidence of impact of maternal HIV infection on immunoglobulin levels in HIV-exposed uninfected children. AIDS Res Hum Retroviruses 2010; 26:967-75.
31. Kuhn L, Coutsoudis A, Moodley D, et al. T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission. AIDS Lond Engl 2001; 15:1-9.
32. Slyker JA, Lohman-Payne BL, Rowland-Jones SL, et al. The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants. AIDS Lond Engl 2009; 23:117-24.
33. Le Chenadec J, Mayaux M-J, Guihenneuc-Jouyaux C, Blanche S, Enquête Périnatale Francąise Study Group. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS Lond Engl 2003; 17:2053-61.
34. Pacheco SE, McIntosh K, Lu M, et al. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study. J Infect Dis 2006; 194:1089-97.
35. Bunders M, Thorne C, Newell ML, European Collaborative Study. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS Lond Engl 2005; 19:1071-9.
36. André-Schmutz I, Dal-Cortivo L, Six E, et al. Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination. J Infect Dis 2013; 208:235-43.
37. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS Lond Engl 2008; 22:289-99.
38. Morlat P, CNS, ANRS. Prise en charge médicale des personnes vivant avec le VIH [Internet], 2013. Available at: http://www.sante.gouv.fr/IMG/pdf/Rapport-Morlat-2013-Mise-en-ligne.pdf. Accessed 27 April 2014.
39. Jasseron C, Mandelbrot L, Tubiana R, et al. Prevention of mother-tochild HIV transmission: similar access for sub-Sahara African immigrants and for French women?. AIDS Lond Engl 2008; 22:1503-11.
40. Winkelstein JA, Marino MC, Lederman HM, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 2006; 85:193-202.